Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sugg

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Vaccine|April 1, 1994
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogensA J Conley, P Conard, S Bondy, et al.
Annals of Internal Medicine|January 5, 2002
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999Joette M Meyer, Nancy P Silliman, Wenjin Wang, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
Journal of Medicinal Chemistry|July 5, 1996
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agentsB R Henke, T M Willson, E E Sugg, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Vaccine|April 1, 1994
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogensA J Conley, P Conard, S Bondy, et al.
Annals of Internal Medicine|January 5, 2002
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999Joette M Meyer, Nancy P Silliman, Wenjin Wang, et al.
Journal of Medicinal Chemistry|August 18, 1995
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligandsM Dezube, E E Sugg, L S Birkemo, et al.
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
Journal of Medicinal Chemistry|July 5, 1996
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agentsB R Henke, T M Willson, E E Sugg, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|January 25, 2002
Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteresDavid E Uehling, Kelly H Donaldson, David N Deaton, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Journal of Medicinal Chemistry|April 28, 2006
Biarylaniline phenethanolamines as potent and selective beta3 adrenergic receptor agonistsDavid E Uehling, Barry G Shearer, Kelly H Donaldson, et al.
Pageof 6